Navigation Links
MetaMorphix, Inc. Announces Sale

CALVERTON, Md., Feb. 4, 2011 /PRNewswire/ -- MetaMorphix, Inc., an animal biotechnology company, announced its intention to sell all, or substantially all, of its assets as part of its reorganization under a sale in Chapter 11 pursuant to section 363 of the Bankruptcy Code. The Company also announced that American MedTech Advisors has been retained to assist in the sale of the Company.

The Company will be accepting bids for any or all of its assets until 4:00 p.m., March 3, 2011. Qualified bidders will be invited to participate in an auction, which will be held on March 8, 2011 at 9:00 a.m. at the law offices of Pinckney, Harris & Weidinger, LLC, 1220 N. Market St., Wilmington, DE. Final court approval is expected on March 9, 2011.

MetaMorphix, Inc. has two technology platforms -- animal genomics, and growth and differentiation factors. The animal genomics business is operated as a wholly owned subsidiary, MMI Genomics, which is located in Davis, CA. MMI Genomics is a leading provider of DNA testing for the livestock and companion animal markets. For the livestock industry, MMI Genomics offers parentage and disease testing for cattle breeders and breed registries. It also has developed predictive markers for several of the most important production and meat quality traits in beef cattle. MMI Genomics has also licensed its trait prediction technology to livestock breeders -- Hubbard in chicken, and Newsham in swine. For the companion animal industry, MMI Genomics offers parentage testing for canine breed registries. As well, the Company was the first to introduce a DNA test that can determine the breed composition in mixed-breed dogs.

MetaMorphix's growth and differentiation platform was licensed from The Johns Hopkins University and is operated from the corporate headquarters in Calverton, MD. The Company's lead growth factor is Myostatin, which is a natural regulator of skeletal muscle. Potential indications for Myostatin in human health include treatment of muscular diseases such as muscle wasting, age-related loss of muscle, and muscular dystrophy. Myostatin has also been shown to have potential for the treatment of metabolic diseases such as Type II diabetes and obesity. In agriculture, Myostatin has the potential to dramatically improve livestock production efficiency and meat quality.For more information on the Company, please contact:Dan D'AgostinoAmerican MedTech Advisors212-209-3885 ddagostino@ameritechadvisors.comorLinda Yaswen, Ph.D.VP Strategic PlanningMetaMorphix, Inc.301-575-2512lyc@metamorphixinc.comFor information on the bidding procedures, please contact:Adam Hiller, Esq. or Kevin Capuzzi, Esq.Pinckney, Harris & Weidinger, LLC302-504-1497

SOURCE MetaMorphix
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
2. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
3. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
4. Anesiva Announces Second Quarter 2008 Financial Results and Update
5. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
6. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
7. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
8. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. ThirdBiotech Announces Kemeta as Newest Sponsor
10. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
11. Chromos obtains interim order in connection with arrangement, announces annual and special meeting of shareholders and confirms mailing of information circular
Post Your Comments:
(Date:6/27/2016)... Lemonade Stand Foundation (ALSF), a leading national childhood cancer ... bioinformatics lab, using ,big data, to advance the pace ... Liz Scott , co-executive director of ALSF and Alex,s ... Washington, D.C. , hosted by Vice President ... pediatric cancer research and awareness. The ...
(Date:6/27/2016)... , June 27, 2016  Global demand for ... percent through 2020 to $7.2 billion.  This market ... beverages, cleaning products, biofuel production, animal feed, and ... diagnostics, and biocatalysts). Food and beverages will remain ... by increasing consumption of products containing enzymes in ...
(Date:6/27/2016)... ON , June 27, 2016 /PRNewswire/ - BIOREM Inc. ... has been advised by its major shareholders, Clean Technology ... United States based venture capital ... shares of Biorem (on a fully diluted, as converted ... the disposition of their entire equity holdings in Biorem ...
(Date:6/27/2016)... SAN DIEGO , June 27, 2016  Sequenom, ... company committed to enabling healthier lives through the development ... Supreme Court of the United States ... Federal courts that the claims of Sequenom,s U.S. Patent ... the patent eligibility criteria established by the Supreme Court,s ...
Breaking Biology Technology:
(Date:6/27/2016)... June 27, 2016 Research and Markets has ... 2016-2020" report to their offering. ... America to grow at a CAGR of 12.28% during ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:6/22/2016)... American College of Medical Genetics and Genomics was once again ... of the fastest-growing trade shows during the Fastest 50 Awards ... Las Vegas . Winners are ... of the following categories: net square feet of paid exhibit ... 2015 ACMG Annual Meeting was ranked 23 out of 50 ...
(Date:6/22/2016)... 2016   Acuant , the leading ... has partnered with RightCrowd ® to ... Management, Self-Service Kiosks and Continuous Workforce Assurance. ... functional enhancements to existing physical access control ... with an automated ID verification and authentication ...
Breaking Biology News(10 mins):